The Scientist

» drug development and microbiology

Most Recent

image: Bacteria to Blame?

Bacteria to Blame?

By | August 18, 2015

T cells activated in the microbe-dense gut can spark an autoimmune eye disease, a study shows. 

2 Comments

image: Report: Impact of Biomedical Research Slipping

Report: Impact of Biomedical Research Slipping

By | August 18, 2015

Despite dramatic increases in publications, the last 50 years have seen relatively little return on investment for US public health, a study suggests.

15 Comments

image: The Search for Persisters

The Search for Persisters

By | August 11, 2015

Lyme disease–causing bacteria can outmaneuver antibiotics in vitro and manipulate the mouse immune system.

0 Comments

image: Doctor Who Blocked Thalidomide Dies

Doctor Who Blocked Thalidomide Dies

By | August 11, 2015

Frances Oldham Kelsey, a physician who halted use of a drug that caused birth defects in babies, has passed away at age 101.

0 Comments

image: Bacterial Enzyme an Antismoking Aid?

Bacterial Enzyme an Antismoking Aid?

By | August 10, 2015

A compound that degrades nicotine before it reaches the brain could serve as a successful smoking cessation therapy, according to an in vitro study.

0 Comments

image: FDA Approves 3-D–Printed Drug

FDA Approves 3-D–Printed Drug

By | August 4, 2015

The US Food and Drug Administration green lights the first medicine produced by a 3-D printer for use in the human body.

1 Comment

image: Subway Microbiome Study Revised

Subway Microbiome Study Revised

By | August 4, 2015

Researchers tone down their highly publicized study that reported the presence of deadly pathogens on New York City subways.

0 Comments

image: TB Traces

TB Traces

By | August 1, 2015

Take a trip to the mummy museum in Vác, Hungary, to see the human remains that helped researchers learn more about the origins of tuberculosis in Europe.

0 Comments

image: Anthrax Sent in Error to 86 Labs

Anthrax Sent in Error to 86 Labs

By | July 29, 2015

A US Army lab shipped live spores of the deadly bacterium because of improper irradiation protocols, a Department of Defense review has found.

1 Comment

image: Teva Buys Allergan Generics for $40.5 Billion

Teva Buys Allergan Generics for $40.5 Billion

By | July 27, 2015

Meanwhile, Allergan acquires drug developer Naurex in a $560 million deal. 

0 Comments

Popular Now

  1. Consilience, Episode 3: Cancer, Obscured
  2. RNAi’s Future in Drug-Target Screening
    News Analysis RNAi’s Future in Drug-Target Screening

    A recent CRISPR study contradicted years of RNA interference research on a well-studied cancer drug target. But is it the last nail in the coffin for RNAi as a screening tool? 

  3. A History of Screening for Natural Products to Fight Cancer
  4. Streakers, Poopers, and Performers: The Wilder Side of Wildlife Cameras
AAAS